Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.3K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.3K
Hybridoma Technology01:31

Hybridoma Technology

17.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

264
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
264
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

311
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
311
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

233
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
233
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

3.4K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated single-cell and spatial transcriptomic profiling in ALS uncovers peripheral-to-central immune infiltration and reprogramming.

Nature neuroscience·2026
Same author

Design of Neuronal Supramolecular Scaffolds Integrating Cell Signaling and Electrical Conductivity.

ACS biomaterials science & engineering·2026
Same author

Peptide-Induced Ferroelectricity in Charge-Transfer Supramolecular Materials.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

A role for the cholinergic neuron circadian clock in RNA metabolism and mediating neurodegeneration.

Life science alliance·2025
Same author

TDP-43 dysfunction compromises UPF1-dependent mRNA metabolism in ALS.

Neuron·2025
Same author

TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD.

Nature neuroscience·2025
Same journal

Neuroimmunology of Epilepsy: Mechanisms, Treatments, and Clinical Insights.

Epilepsy currents·2026
Same journal

Clinical Failure Validates a Fifth Predictive Preclinical Antiseizure Medicine Discovery Model.

Epilepsy currents·2026
Same journal

Hearing in Our Sleep-Can We Drown Out Epileptic Spikes and Boost Cognition?

Epilepsy currents·2026
Same journal

Sleep Smarter: Optimal Sleep May Preserve Cognition and Reduce Dementia Risk in Focal Epilepsy.

Epilepsy currents·2026
Same journal

Microglia-Mediated Disinhibition: Taking the Brakes off Epileptic Networks.

Epilepsy currents·2026
Same journal

Brainstem Disinhibition Destabilizes Breathing in Dravet Syndrome, Leading to Sudden Unexpected Death in Epilepsy (SUDEP).

Epilepsy currents·2026
See all related articles

Related Experiment Video

Updated: Feb 4, 2026

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

21.1K

Modeling Pediatric Epilepsy Through iPSC-Based Technologies.

Dina Simkin1, Evangelos Kiskinis2

  • 11Postdoctoral Fellow, The Ken & Ruth Davee Department of Neurology and Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL.

Epilepsy Currents
|September 27, 2018
PubMed
Summary
This summary is machine-generated.

This review covers modeling pediatric epileptic encephalopathies using induced pluripotent stem cell (iPSC)-based technologies. It explores the benefits, challenges, and proposes standards for this innovative research approach.

More Related Videos

Generation of a Human iPSC-Based Blood-Brain Barrier Chip
10:20

Generation of a Human iPSC-Based Blood-Brain Barrier Chip

Published on: March 2, 2020

13.6K
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

8.8K

Related Experiment Videos

Last Updated: Feb 4, 2026

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

21.1K
Generation of a Human iPSC-Based Blood-Brain Barrier Chip
10:20

Generation of a Human iPSC-Based Blood-Brain Barrier Chip

Published on: March 2, 2020

13.6K
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

8.8K

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Genetics

Background:

  • Pediatric epileptic encephalopathies (PEEs) are severe neurological disorders.
  • Current modeling approaches have limitations in recapitulating disease complexity.

Purpose of the Study:

  • To review in vitro induced pluripotent stem cell (iPSC)-based technologies for modeling PEEs.
  • To discuss the advantages and challenges of iPSC-based modeling.
  • To propose standards for the field.

Main Methods:

  • Review of current literature on iPSC-based disease modeling.
  • Focus on applications in pediatric neurological disorders.
  • Analysis of technological benefits and limitations.

Main Results:

  • iPSC technology offers a promising avenue for studying PEEs in vitro.
  • Challenges include standardization, scalability, and recapitulating in vivo complexity.
  • Specific iPSC-derived neuronal models show potential for disease mechanism elucidation.

Conclusions:

  • iPSC-based modeling holds significant potential for advancing PEE research.
  • Establishing standardized protocols is crucial for reliable and reproducible results.
  • Further development is needed to fully harness iPSC technology for PEEs.